Axogen (AXGN) Amortizatization of Intangibles (2010 - 2022)
Axogen's (AXGN) quarterly Amortizatization of Intangibles came in at $458000.0 in Q4 2022, up 21.49% year-on-year from $377000.0 in Q4 2021, and up 3.15% quarter-over-quarter from $444000.0 in Q3 2022.
Axogen (AXGN) Amortizatization of Intangibles (2010 - 2022) Analysis & Trends
Axogen's Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $458000.0 for Q4 2022.
- On a quarterly basis, Amortizatization of Intangibles rose 21.49% year-over-year to $458000.0 in Q4 2022; TTM through Dec 2022 was $1.8 million, a 1.89% decrease from a year earlier, with the FY2023 full-year figure at $1.1 million, down 39.69% from the prior year.
- Amortizatization of Intangibles grew to $458000.0 in Q4 2022 per AXGN's latest filing, from $444000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $500000.0 in Q1 2021 and bottomed at $332000.0 in Q2 2020.
- The 4-year median for Amortizatization of Intangibles is $458000.0 (2021), against an average of $447125.0.
- Across the five-year window, Amortizatization of Intangibles dropped 26.87% in 2020 and soared 38.55% in 2021, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $469000.0 in 2019, then increased by 5.54% to $495000.0 in 2020, then retreated by 23.84% to $377000.0 in 2021, then gained by 21.49% to $458000.0 in 2022.
- Per Business Quant, the three latest AXGN Amortizatization of Intangibles figures stand at $458000.0 (Q4 2022), $444000.0 (Q3 2022), and $432000.0 (Q2 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Axogen | 2.12 Bn | 2.02 Bn | 46.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 458,000.00 |
| Dec 31, 2022 | 458,000.00 |
| Sep 30, 2022 | 444,000.00 |
| Sep 30, 2022 | 444,000.00 |
| Jun 30, 2022 | 432,000.00 |
| Jun 30, 2022 | 432,000.00 |
| Mar 31, 2022 | 427,000.00 |
| Mar 31, 2022 | 427,000.00 |
| Dec 31, 2021 | 377,000.00 |
| Dec 31, 2021 | 377,000.00 |
| Sep 30, 2021 | 458,000.00 |
| Sep 30, 2021 | 458,000.00 |
| Jun 30, 2021 | 460,000.00 |
| Jun 30, 2021 | 460,000.00 |
| Mar 31, 2021 | 500,000.00 |
| Mar 31, 2021 | 500,000.00 |
| Dec 31, 2020 | 495,000.00 |
| Dec 31, 2020 | 495,000.00 |
| Sep 30, 2020 | 480,000.00 |
| Sep 30, 2020 | 480,000.00 |